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Not everything that can be counted counts, and 
not everything that counts can be counted. 
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Preface 
 
In recent years, a large number of reproductive health indicators have been put forward by 
various organizations.  This paper is designed to help readers, be they researchers, program 
managers, policymakers, or advocates, sift through and evaluate which potential indicators 
might be useful in a particular programmatic context.  It was initially prepared as a 
background manuscript for a Population Council meeting on reproductive health indicators 
held in Cairo in March 1998.  The manuscript has since been modified to incorporate ideas 
and comments expressed at that meeting, as well as to include input from other Population 
Council colleagues.   
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Section 1.  Introduction 
The 1994 International Conference on Population and Development (ICPD) in Cairo led to an 
explosion of interest in reproductive health.  Perhaps the most important outcome of this 
meeting was a shift in focus among the population and international health establishment 
from population control targets to womens health issues and womens reproductive rights.  
This shift has created a demand for tools with which to measure reproductive health.  Indeed, 
over the last ten years, indicators for this purpose have been borrowed from other fields, 
created anew, and refined in a number of important ways. 
 
Valid and reliable indicators are particularly important as many international organizations 
continue to invest in reproductive health programs throughout the world.  Indicators are 
needed for identifying problems that require attention, as well as for highlighting specific 
populations or subpopulations that have the greatest need for interventions and services.  
Once programs and services have been implemented, indicators can provide valuable 
information on what works, what does not, and whether programs and services are having an 
impact on the problems they are designed to address.   
 
A variety of institutions and organizations have attempted to develop reproductive health 
indicators to meet these needs.  The World Health Organization (WHO), for example, has 
developed a variety of indicators to monitor progress toward their efforts to ensure health for 
all by the year 2000.  WHO has also collaborated with the United Nations Childrens Fund 
(UNICEF) on developing indicators, including a few reproductive health indicators, to assess 
progress toward the specific targets set at the 1990 World Summit for Children.  
Additionally, the United States Agency for International Development (USAID) has been 
engaged, through the EVALUATION Project, in the development of indicators, largely for 
monitoring reproductive health programs.   
 
These efforts, however, have been plagued by several shortcomings.  First, they have focused 
almost exclusively on monitoring programs at the national level to the exclusion of other 
uses, such as evaluating womens health status.  Second, no standard definitions for many 
common reproductive health problems have been established across communities, regions, 
and organizations, an omission leading to confusion and questions about the interpretation of 
available data.  Third, the data necessary for calculating many of the reproductive health 
indicators developed by these organizations are not often readily available or, where 
available, are frequently of dubious quality.  Finally, many indicators have been adapted from 
other areas of public health without due consideration of their applicability to reproductive 
health. 
 
Perhaps the most significant advance in the development of reproductive health indicators 
has been the implementation of a number of in-depth, community-based studies of 
reproductive health.  These studies have focused attention on womens health issues and were 
instrumental in the shift of interest to this subject at the ICPD conference.  These studies took 
a new approach to measuring womens reproductive health, using both qualitative and 
quantitative data-collection strategies and amassing information not only on morbidity, but 
also on womens experience of ill health. 
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Community-based studies, as they have been conducted, though, are not without 
methodological problems.  For example, to date, they have been conducted in only a few 
discrete settings and have not been replicated in a wider range of countries and populations, 
using a standardized protocol.  Additionally, the innovative indicators used in these studies 
need to be validated and their technical robustness must be demonstrated.  
 
This paper sets out to lay the groundwork for a discussion of the means by which to  develop 
and refine reproductive health indicators. It does not provide an exhaustive review of 
reproductive health indicators or of the technical aspects of their development and 
calculation, but rather provides the foundation for a discussion of future research needs in 
this area.   
 
Presented below is a conceptual framework for guiding research on reproductive health 
indicators followed by a review of the potential purposes for which such indicators can be 
used.  The next section includes a brief overview of how indicators are derived and discusses 
technical criteria that can be used to assess them.  The fifth section describes the data sources 
typically used to calculate reproductive health indicators, their advantages and their 
disadvantages.  Section six illustrates the concepts that have been outlined by reviewing the 
particular qualities of a few sample indicators.  The final section of the paper offers a brief 
catalogue of other agencies that have made significant contributions to the development of 
reproductive health indicators and the work that they have undertaken. 
 
Section 2.  A Conceptual Framework 
 
The development of useful indicators is best guided by a theoretical framework that 
postulates the relationship between different variables of interest.  Such a framework requires 
a detailed understanding of the variety of factors that might affect an outcome of interest, 
typically a disease state or health condition.  The input-output-outcome-impact framework 
shown in Figure 1 is designed for identifying indicators for programmatic purposes.  This  
 
framework suggests a relationship between the typical activities of health improvement 
programs, inputs and processes, and relates them to particular outcomes and impacts, which 
Figure 1:  Levels of evaluation 
Process Evaluation 
 
Impact Evaluation 
 
INPUT 
 
OUTPUT OUTCOME IMPACT 
(Program design and plan) (Implementation) Change in: Change in: 
 People  Information  Awareness  Morbidity 
 Goods  Skills  Behavior  Mortality 
 Services  Services  Health practices  Disability 
 Money    Health 
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are usually defined as changes in behavior and health status, respectively.  Although 
outcomes are usually the point of greatest interestchanges in health status are typically the 
ultimate goal of any programthey are often difficult to measure, and the link to program 
activities per se is difficult to establish.  Changes in health outcomes can be related to a 
variety of factors, many of which are unrelated to the program in question.  Thus, input and 
process indicators are often used as surrogates to capture the activities of a program that 
presumably have the desired influence on the condition of interest, or on overall health status.  
Typically, although inputs are supply-side oriented, outcomes and impacts are measured at 
the level of the individual who uses health services or in the community at large. 
 
Fortney (1995) has described a potential framework for understanding the components of 
reproductive morbidity.  This framework separates reproductive morbidity (a subset of 
womens morbidity) into obstetric (maternal), gynecologic, and contraceptive categories.  
Such distinctions are important in order to assure that rates of reproductive morbidity are 
comparable between studies.  These categories can help researchers to clarify what specific 
type of morbidity they are interested in, and how it might be related to other, more general, or 
more specific, types of morbidity.  This framework can also help focus measurement efforts 
on those areas where no or little reliable information exists. 
 
This framework does not provide information on determinants of reproductive health 
outcomes of interest, however.  Such a framework would be helpful for identifying different 
points along causal pathways that could be targeted for indicator development.  These types 
of frameworks have been developed in other areas, for example child and infant mortality and 
morbidity (Mosley-Chen framework).  Different frameworks could be developed for different 
components of reproductive health, including maternal mortality/morbidity; reproductive 
tract and sexually transmitted infections (RTIs/STIs) including HIV; and violence against 
women.  The development of such frameworks requires further research on the determinants 
and covariates of specific reproductive morbidities and conditions.  Some of this information 
can be gleaned from the in-depth community-based studies that have been conducted to date, 
but more studies are needed in different areas and populations of women.  A better 
understanding of the determinants of reproductive morbidity would help to focus the 
discussion of reproductive health indicators. 
 
Conceptual frameworks are important for developing indicators because they take into 
consideration many determinants of broad health outcomes.  Understanding the determinants 
or components of health outcomes and their effect on the outcome of interest is critical for 
choosing valid indicators.  Although we may often rely on input or process indicators because 
measuring changes in outcome is difficult or impossible, a link between the determinant or 
component we are addressing and the outcome of interest must be established, and other 
determinants or components that may affect our ability to effect change in that outcome must 
be recognized. 
 
Section 3.  Purposes of Reproductive Health Indicators 
The purpose for which an indicator will be used is critical in selecting one that is appropriate, 
and one that will lead to accurate conclusions.  Because each measure of an aspect of 
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Box 1: Get out your dictionaries.  Ensuring 
standardized case definitions has proved to be 
a particular problem. Definitions of 
reproductive morbidities vary by country,  by 
region, and also by provider.  For example, 
when Bulut et al. (1995) reanalyzed the 
prevalence and distribution of pelvic 
inflammatory disease (PID) that were reported 
in their study employing the criteria used by 
researchers in three other studies, the 
estimated prevalence ranged from 3.7 percent 
to 30.4 percent. 
reproductive health requires a different level of precision or refinement, a single indicator can 
rarely serve a variety of purposes.  Several possible uses of reproductive health indicators are 
listed below by the level of precision required for each, in order of increasing precision. 
 
Advocacy.  Indicators are often used by advocates, including womens health advocates, 
advocates for better health of underserved populations, and health professionals who play the 
role of advocate to governments, donors, or individuals.  In general, less refined indicators 
may be useful for advocacy purposes.  Statistics such as the number of maternal deaths per 
year resulting from unsafe abortion or the average number of women who die in childbirth 
per day are often sufficient to raise awareness about or engage interest in a problem.  For 
advocacy purposes, magnitude tends to take precedence over precision.  Advocates usually 
do not have the resources to undertake research in order to generate the indicators they 
require, and such research is not the focus of their work.  Typically, therefore they use readily 
available indicators, such as those that are calculated annually and published in accessible 
reports. 
 
Needs Assessment/Feasibility Studies.  Reproductive health indicators may also be used to 
assess needs or to demonstrate the feasibility of a particular program.  Although many 
reproductive health indicators used for this purpose may also play a role in advocacy by 
highlighting a specific problem that has not received sufficient attention, these indicators are 
intended to guide a project or intervention design in a specific community.  As such, they 
must be more precise than those used for advocacy alone.  For example, the indicator must 
reflect the current reproductive health status of the target population. Yet, because 
indicators used to assess needs are usually focused on establishing baseline figures, 
rather than on evaluating the effectiveness of an intervention, they may be less precise than 
those used for monitoring or evaluating the impact of a program. 
 
Group, Regional, and International 
Comparisons. Indicators used to compare 
reproductive health information across groups, 
regions, or countries require greater precision 
than do those employed to assess program 
needs.  When reproductive health measures 
are used to compare information across 
groups, regions, or countries rather than to 
determine the health status of a single 
population, comparability of the populations 
must be considered in terms of such factors as 
age structure and access to health services.  
In addition, the definition 
of the condition being measured by the 
indicator must be the same for the populations being compared.  In order to make a valid 
comparison, for  example, to state that more women in country A than in country B suffer 
from pre-eclampsia, the national rates of pre-eclampsia must not differ because pre-eclampsia 
is defined more liberally or frequently in country A than it is in country B. 
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Box 2: The multipurpose indicator.  A 
single indicator best serves a single (or 
limited number of) function(s).  Indicators 
developed for a specific purpose may not 
have characteristics critical for other 
purposes.  For example, the number of 
maternal deaths per year by country may 
be used by advocates to highlight the 
differential risks of maternal death around 
the world and to stimulate funding for 
improvements in maternal health services, 
but maternal deaths occur too rarely to 
measure program impact.  Similarly, the 
inconsistency of definitions of maternal 
death, and the differences in age structures 
of populations, may make international or 
interregional comparisons meaningless. 
 
Monitoring Existing Programs. An extensive literature is available on indicators that can be 
used to monitor programs (Bertrand et al., 1996; Rashad et al. 1994; Rossi and Freeman 
1993; Smith and Morrow 1991.)  One of the main issues in choosing an indicator is ensuring 
that it reflects the activities of the program itself, rather than extraneous trends in the health 
service or catchment population.  The input-process-outcome-impact framework shown in 
Figure 1 can help identify appropriate indicators for monitoring programs.  Although 
policymakers or program managers may be more interested in the outcome of a program or 
intervention (see below), input and process indicators are most often used for routine 
monitoring because they are directly related to program activities.  Input refers to the 
resources provided by a program (for 
example, drugs supplied to a clinic for 
treatment of STIs or contraceptive 
methods on hand), whereas process 
denotes the measure of programmatic 
activities undertaken (for example, 
number of clients counseled about HIV 
prevention or number of condoms 
distributed).  Because program 
monitoring often occurs at routine 
intervals in a program cycle, both input 
and process indicators should be 
available disaggregated by specified time 
periods.  For this reason, data collection 
for these indicators should be 
incorporated into the program or 
intervention design insofar as is possible.  
 
Assessing the Impact of Interventions.  
Assessing the impact of interventions or 
programs has proved more difficult than has monitoring program inputs or activities.  
Identifying the impact of a program requires that a link be established between program 
activities and any change in disease status or other desired outcomes.  Often, documenting 
such link in the population under study requires not only lengthy and costly follow-up but 
also necessitates an understanding of the disease process and a clear idea of where in that 
process the program might cause a change.  For example, a program undertaken to reduce the 
incidence of HIV might include counseling of clients with STDs about safer sex practices and 
provision of condoms.  Proving, however, that counseling and the provision of condoms 
results in behavioral change and a reduced risk of acquiring the disease is much more 
difficult than determining that these activities have taken place.  In order to establish such a 
relationship, the co-factors affecting the population of interest that might also have an impact 
upon the spread of HIV must be accounted for.  Many of these co-factors are difficult to 
quantify; others may not even be known.  Furthermore, identifying aggregate indicators of 
impact is difficult for programs that provide integrated services or more than one service, or 
those that do not have disease-specific goals.  The goal of the latter sort of program 
 6
may be overall improvement in reproductive health for which no clear or operational 
definition exists, or improvements in a variety of outcomes that may or may not show 
uniform improvement or decline. 
 
Resource Allocation and Strategic Planning.a  Indicators of the cost-effectiveness of 
programs or interventions are often used to plan the combination of services to be offered at 
various service delivery points, and to develop national or regional strategies of health-care 
provision.  Collecting data with which to calculate these indicators is extremely difficult 
 and time consuming.  Indicators such as disability-adjusted life years (DALYs) saved per 
unit cost or other measures of cost-effectiveness require that all the costs of an intervention 
be calculated, including the various components of capital costs.  Additionally, a number 
of assumptions must be made regarding depreciation, inflation, and the amount of various 
capital inputs, including staff salaries, that should be attributed to the intervention or 
program.  Such calculations often involve extensive and expensive costing studies.  
Moreover, measures of cost-effectiveness may be incomparable across regions because of the 
variability in costs of imported materials or local labor.   
 
Section 4. Criteria for Assessing Indicatorsb  
 
Typically, more than one indicator can be used to summarize the same phenomenon or 
condition.  For instance, the quality of antenatal services can be assessed, to some degree, by 
an indicator consisting of  the number of visits made by pregnant women, as well as by the 
proportion of pregnant women having their first visit in the first trimester.  In order to 
select the most useful indicator, appropriate selection criteria must be agreed upon.  A single 
indicator is unlikely to fulfill all of the agreed-upon criteria, however.  Consequently, the 
relative importance of various selection criteria must be weighed depending on how the 
indicator will be used.  Some of the most commonly used selection criteria (World Health 
Organization 1997) are reviewed below.  Although the list is not comprehensive, it can be 
used to spark discussion of other potential criteria.  
Scientific Soundness.  Indicators should possess proved technical robustness.  The scientific 
soundness of an indicator is comprised of four main components: validity, reliability, 
specificity, and sensitivity. 
 
                                                 
a Although a large literature exists on measuring the cost-effectiveness of programs and 
services (Barnum 1987; Bobadilla et al. 1994; Murray 1993; Murray et al. 1994; World 
Health Organization 1988), indicators for this purpose are not discussed here. 
b As background to this section, we have provided a description of how indicators are derived 
in Appendix I.  While much of the information presented in this section is not specific to 
indicators or to reproductive health, we have approached it with an eye focused on the 
development of reproductive health indicators.  As much as possible, we offer reproductive 
health examples. 
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Validity refers to the extent to which an indicator represents what it is supposed to, or, in 
other words, to how well it reflects reality.  Validity can be evaluated on several grounds: 
First, the extent to which a measurement corresponds to theoretical concepts concerning the 
phenomenon under study can be determined.  Whether the measure being used to describe an 
issue or factor is in fact describing that issue or factor can be assessed.  For example, a 
womans report concerning her use of oral contraceptives is likely to have greater validity 
than her husbands report.  Finally, whether the current measure of the phenomenon produces 
results that are closely related to other independent measures of the same phenomena can be 
evaluated.  For example, results can be triangulated from different data-collection methods.  
In a groundbreaking community-based study in Giza, Egypt, the authors measured the 
validity of self-reports of reproductive tract infections and genital prolapse by comparing and 
measuring the association between self-assessments and medical diagnoses (Zurayk et al. 
1995).  If the two measures were highly associated, then self-assessment could serve as an 
inexpensive measure of health that stood the test of validity. 
 
Reliability reflects the extent to which an indicator produces the same results if it is assessed 
more than once under the same conditions (that is, with the same measurement tool and the same 
population).  Count data, such as the number of maternal deaths in a population, are generally 
reliable if records are available.  On the other hand, when attitudes, beliefs, or perceptions are 
being measured, the same questions may generate different responses depending on the 
respondent's mood, state of mind, or interest in participating in the survey, as well as on the 
relationship between the respondent and the interviewer and where the interview is 
conducted. 
 
Box 3:  Validating womens self-reports of major obstetric complications.  In recent 
years, several Safe Motherhood studies have assessed the usefulness of asking women 
about signs and symptoms of obstetric complications using survey methods.  (Six studies 
have been conducted to date in Benin, Bolivia, El Salvador, Ghana, Indonesia and the 
Philippines; unfortunately only two are published: Stewart et al. 1995; Ronsmans et al. 
1997.)  These studies were undertaken to determine if self-reported symptoms, compared 
with clinical and/or laboratory results, can predict correctly the occurrence of major 
obstetric complications.  In 1996, a task force established to review the data from these 
studies concluded that interview data are unlikely to be valid or reliable for identifying the 
prevalence of obstetric complications (Stewart et al. unpublished).  The task force reported 
that womens retrospective self-reports of complications are not an accurate means of 
estimating the proportion of women who need medical treatment for obstetric 
complications.  For instance, one of these studies, in which 340 inpatients who had 
presented at a rural district hospital in Ghana with life-threatening obstetric complications 
were interviewed, found that 76 percent of the complicated cases and 75 percent of the 
uncomplicated cases were correctly identified by a self-reported symptoms algorithm, 
representing substantial false-positive and false-negative rates (Sloan et al. unpublished). 
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Box 4:  Whos asking the question?  Research 
in various settings suggests that respondents 
reports of symptoms vary by who is 
interviewing them.  Indeed, several studies 
show that women report fewer symptoms to lay 
interviewers than to clinicians.  For example, in 
a community-based study conducted in Turkey, 
just over one-third of respondents reported 
experiencing reproductive morbidity when 
interviewed at home, whereas more than 80 
percent reported the presence of a reproductive 
malady to the clinician when they were 
examined at a clinic (Bulut et al., 1995).  The 
authors concluded that the participants 
memories were jogged during the home 
interview, leading them to report more 
morbidity to the clinician.  Other reasons for 
this finding may include womens expectations 
of treatment and the presumed confidentiality of 
the clinic setting.  Similar results have been 
reported in general health surveys as well (Ross 
et al. 1986). 
Sensitivity and specificity are typically used in 
the field of epidemiology to measure the 
validity of screening tests.  Sensitivity is the 
proportion of persons in the screened 
population who are accurately identified as 
diseased by the screening test for the disease.  
Specificity is the proportion of truly non-
diseased persons who are accurately identified 
by the screening test.  The definitions of these 
measures, however, are often interpreted more 
broadly in the context of reproductive health 
indicators.  For instance, sensitivity is used to 
express whether an indicator reflects changes 
in the factor of interest. Similarly, specificity 
refers to the ability of an indicator to reflect 
only changes in the issue or factor under 
consideration without being influenced by 
changes in other factors. 
 
Data Requirements.  In order to minimize the 
burden of data collection on service providers 
and other health personnel, indicators should 
be based on data that are routinely collected 
and available data, if possible.  Readily 
available data sources are often plagued by problems of representativeness and reliability, 
however (see below).  For this reason, data from population-based surveys are often needed 
to supplement routinely collected data.  Using these surveys, however, increases costs and, 
consequently, may make indicators based on these surveys less accessible to those working in 
the field. 
 
Representative.  Ideally, indicators should be representative of all the issues or populations 
that they are expected to cover.  Generally, data routinely collected by health institutions have 
limited coverage and, consequently, reflect only a select group.  For example, the indicator 
"prevalence of severe anemia in pregnant women" is not representative because not all 
pregnant women are screened for anemia.  In many cases, however, supplementing routine 
data can increase the representativeness of a given indicator.  For instance, the indicator 
"number of facilities with functioning comprehensive essential obstetric care per 500,000 
population," which appears on the short list of national and global indicators published by 
WHO (see section 5), would be more representative if, in practice, data were collected from 
both private and public facilities. 
 
Ethical.  Data collection, analysis, and presentation should protect the rights of the individual 
to confidentiality, freedom of choice in supplying data, and informed consent regarding the 
nature of the data required. 
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Understandable. Indicators should also be simple to define and interpret.  Consequently, 
WHO discourages the use of composite indicators. 
 
Section 5.  Data Sources 
 
We devote this section to discussion of various data sources for reproductive health 
indicators and what can be gleaned from each of them to measure reproductive health. 
 
5.1  Traditional Data Sources 
 
Traditionally, data for calculating indicators have come from four main sources: vital 
statistics, censuses, service-delivery statistics, and sample surveys.  The benefits and 
drawbacks of using data from each of these sources and the information relevant to 
reproductive health indicators that can be obtained from them are described below. 
 
Vital Statistics. Vital statistics are data collected routinely on live births, deaths, marriages, 
and, in some cases, abortions. In theory, vital statistics provide a large amount of information 
on a continuous basis with complete coverage of a population, although the events recorded 
may be limited in scope and strictly defined.  In most countries today, and particularly in 
developing countries, however, vital statistics are rarely routinely collected, or are collected 
only from certain areas and socioeconomic classes.  The infrastructure required to aggregate 
data, as well as the central office for the collection and dissemination of data are often 
lacking.  Moreover, in countries where large proportions of births and deaths occur outside of 
health-care facilities, these events often go unreported, so that available statistics are 
representative of select portions of populations. 
 
Box 5:  Syndromic management of STIs.   In recent years, efforts have increased 
substantially to identify the best management practices concerning STIs in resource-
poor settings.  On the programmatic level, many health-care workers have begun to 
rely on algorithms of symptoms, signs, and risk factors to predict infection without 
the need for laboratory diagnosis.  A detailed review of validation studies in this 
area, however, found that management strategies using symptoms, signs, and risk 
factors have poor predictive value; they miss a substantial proportion of women in 
need of treatment and misclassify many women as requiring treatment when they do 
not (Haberland et al. 1999).  For instance, comparisons of self-reports and medical 
assessments (a combination of clinical examinations and laboratory tests) of RTIs in 
Bangladesh found that only 68 percent of symptomatic women also showed 
evidence of vaginal, cervical, or pelvic infection (Wasserheit et al. 1989).  
Similarly, a study conducted in Giza, Egypt, that compared womens self-reports of 
vaginal discharge with medical assessments (clinical and/or laboratory) of RTIs 
notes a relatively high sensitivity of 79 percent but a low specificity of 26 percent 
(Zurayk et al. 1995). 
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Box 6:  When to ask the question?  The period 
of recall is an important factor determining 
responses, regardless of the type of data-
collection instrument.  A study of postpartum 
morbidity in Bangladesh offers important 
insights on this issue (Goodburn and Graham, 
1996).  In this longitudinal study, women were 
interviewed about their pregnancy and delivery 
experience twice during the antenatal periodat 
pregnancy registration and at seven months 
gestationand four times during the postpartum 
periodwithin five days of birth, at two weeks, 
six weeks and 12 weeks.  Concerning a number 
of events, including whether the respondent had 
had premature or postterm labor, had had labor 
lasting greater than 24 hours, had been attended 
by a traditional birth attendant, had had her 
placenta extracted, and had experienced 
moderate or severe postpartum hemorrhage, the 
proportion of women reporting each event 
decreased at 12 weeks postpartum compared to 
that reporting at five days postpartum.  In the 
context of reproductive health, most studies, 
aside from those assessing pregnancy and 
delivery-related complications, have tended to 
use current-status measurements. 
Even in ideal situations, vital statistics 
provide only a small amount of the 
information needed to derive 
reproductive health indicators because 
events other than births, deaths, and 
marriages are usually not recorded.  
These data, however, can be used to 
calculate the numerators for the total 
fertility rate, the maternal mortality 
rate, and mortality rates from other 
causes.  Vital statistics can also be used 
to calculate the infant mortality rate, 
since, in principle, both births and infant 
deaths are recorded.  Population 
denominators, however, cannot be 
calculated from vital statistics (unless the 
data are complete for a long period of 
time). 
 
The Census.  Reliable data on population 
size gathered by national censuses have 
proved valuable in calculations of 
reproductive health indicators.  
Specifically, censuses can provide 
important information for the 
denominators of many key reproductive 
health indicators, like the maternal 
mortality rate and the infant mortality 
rate.  Censuses usually have good coverage and allow a great deal of information to be 
gathered at one time. Moreover, the information collected in a census can be modified by 
adding new  questions.  A variety of drawbacks are inherent in using census data for 
calculating reproductive health indicators, however.  Censuses are expensive to conduct and 
require significant technical expertise in survey methods.  Additionally, although, in theory, 
censuses provide complete information about a nations population, in reality, census data 
often do not include poor and marginalized populations.  Because censuses occur 
infrequently, establishing figures for intercensal periods involves extrapolation, which may 
lead to inaccurate conclusions.  Finally, censuses rely on self-reported information, making 
much of the data vulnerable to recall bias (see box 6).  Many of the conditions pertinent to 
reproductive health indicators may be impossible or difficult to recall over long periods of 
time.  
 
Service Statistics.  Service statistics are data collected routinely at service-delivery points 
(SDPs) concerning the conditions or diseases observed among clients.  Because service statistics  
usually include results of diagnostic tests (unlike most other data sources described in this 
section), they are not subject to the biases of self-reports.  Service statistics, however, suffer 
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Box 7:  How do you ask the question?  The 
exact format (open-ended or pre-coded) of  a 
survey question and the extent of probing for each 
reproductive health condition are important 
determinants of a response.  Indeed, results from 
several studies suggest that, when compared with 
open-ended questions, symptoms checklists elicit 
higher levels of positive response.  Checklists are 
believed to structure the interview, making it 
easier for the interviewer to conduct.  They also 
jog the memory of the respondent, and provide 
standard definitions of illnesses (Kroeger 1983).  
In a community-based study conducted in Turkey, 
for example, 7 percent of women interviewed 
reported a reproductive health morbidity in 
response to open-ended questions compared with 
65 percent who reported such a condition when it 
appeared on the symptoms checklist (Bulut et al. 
1995).  Several other studies have reported similar 
increases in reporting when a symptoms checklist 
or additional probing follows open-ended 
questions.  In a study of Rajasthani women,  for 
example, the proportion of women reporting 
menstrual problems increased from 28 percent to 
48 percent, and those reporting prolapse increased 
from 10 percent to 20 percent upon detailed 
probing (Grant and Measham 1996).  
from several other inherent 
drawbacks and biases.  First, they are 
available only for populations who 
present at health services and thus 
are not representative of the 
population at large.  Indeed, in the 
developing world, accumulated 
evidence from a variety of settings 
suggests that individuals suffering 
from various ailments or conditions 
rarely seek care at SDPs.  Rural 
women, in particular, may be 
constrained from seeking care for 
several reasons, including lack of 
awareness of the ailment (for 
example, asymptomatic RTIs/STIs), 
inaccessibility of treatment sources 
(as a result of cost, or physical or 
social distance), and lack of sufficient 
autonomy to seek care.  Additionally, 
conditions not culturally defined as 
requiring medical assistance will not 
be included in service statistics unless 
such conditions are discovered in a 
patient presenting for another reason.  
Service 
statistics also suffer from some of the 
same problems as do vital statistics in 
terms of infrastructure and technical requirements.  Finally, health-care workers may not be 
motivated to report service-delivery statistics or may be overburdened with other tasks, 
supervision of reporting may be inadequate, and service-delivery statistics may be oriented 
generally toward administrative matters rather than toward monitoring the health of populations. 
 
In theory, however, service-delivery statistics can provide information about a range of 
conditions that are of interest as reproductive health indicators, including STIs, infertility, 
RTIs, reproductive cancers, and obstetric conditions, as well about contraceptive-use rates 
and number of births attended by a trained clinician.  Service statistics, however, do not 
usually provide an accurate population denominator, because most service-delivery points do 
not have a well-defined catchment population.  If reliable census or survey data exist for an 
area or region, data from these sources can be combined with service statistics to calculate an 
indicator. 
 
Sample Surveys.  Sample surveys, also known as population-based studies, have served as 
data sources for a variety of indicators that are related to reproductive health. In general, 
these surveys are well designed and provide accurate and representative data. Perhaps the 
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most best known sample surveys in the reproductive health field are the Demographic and 
Health Surveys (DHS).  DHS data have been used to calculate indicators such as total 
fertility, wanted fertility, and infant and child mortality rates.  In recent years, the DHS have 
also tested a variety of reproductive health modules, including some addressing domestic 
violence.  Additionally, research groups and government offices in developing countries have 
collaborated with the DHS to interview subsets of the initial DHS sample on specific 
reproductive health issues, such as the sub-survey conducted in the Philippines in 1993 
(National Statistical Office and Macro International 1994).  This survey assessed the 
proportion of women who experienced a variety of reproductive health problems and their 
use of services for these problems. 
 
Like censuses, however, sample surveys are usually dependent upon self-reports of 
information and are, therefore, prone to recall bias.  A number of techniques have been 
developed to deal with this problem.  For instance, many questions used in DHS surveys have 
been pre-tested extensively and validated.  Additionally, sample surveys provide information 
for only one fixed time point, which restricts their usefulness in detecting trends over time.  
Repeat surveys can limit this disadvantage, but the cost and technical expertise required to 
conduct such surveys may be prohibitive.  Sample surveys generally rely on multiple-choice 
questions, with pre-coded responses based on the researchers a priori knowledge.  Although 
such an instrument design encourages the use of standardized terms and concepts, it also 
severely limits the scope for dialogue between the interviewer and the respondent (Assogba 
et al. 1991).  
 
5.2 Alternative data sources 
 
Given the limitations of traditional data sources for the development of reproductive health 
indicators, as discussed above, we now turn to alternative data sources. 
 
Sentinel Surveillance System.  Sentinel surveillance is perhaps best known in the 
reproductive health field for the collection of data related to HIV/AIDS (Mann and Tarantola 
1996).  Yet, sentinel surveillance systems have been used for many years to track trends of 
other conditions, including tuberculosis and acute respiratory infections, and may be relevant 
to the collection of data for other aspects of reproductive health. 
 
A surveillance system is used to monitor trends of a particular condition over time through 
the repeated collection of samples from the same population.  Sentinel sites may be 
established to gather information from populations at different degrees of risk or in different 
geographic areas that are assumed to represent a random sample of the population under 
study.  Consequently, testing at these sites serves as a sentinel by providing a warning of 
what is presumed to be happening in the population at large.   
 
Sentinel surveillance has the advantage of generating data quickly and cost-effectively.  
Additionally, the location of sentinel sites can be changed to reflect shifts in the spread of 
disease.  For instance, as HIV transmission shifted from particular groups, such as commercial  
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Box 8:  Quality of care.  In recent years, there has 
been a growing consensus that indicators of quality of 
care are needed to provide policymakers, program 
managers, and service providers with guidelines for 
improving services.  To date, work in this area has 
focused mainly on contraceptive choice, staff 
competence, and information provided to clients.  The 
quality of client-provider interactions, however, has 
proved particularly difficult to measure.  Indeed, 
providers who are unresponsive to womens requests 
ironically may fare well in some quality assessments.  
For example, a woman who uses oral contraceptive 
pills and requests a refill but receives a thirty-minute 
review of all available contraceptive methods from an 
unresponsive provider would figure in the numerator 
of the indicator percentage of clients given 
information on all available methods, resulting in a 
misleading assessment of the quality of client-provider 
interactions. 
sex workers and intravenous drug 
users, to the general heterosexual 
population, sentinel sites have 
shifted from STD clinics to ante- 
natal clinics. 
 
Sentinel surveillance, however, 
suffers from several methodological  
shortcomings.  First, because 
sentinel surveillance does not 
employ random sampling methods 
the data collected at sentinel sites 
may not be specific enough for 
evaluating program effects or for 
estimating incidence or prevalence 
of a condition in the population as a 
whole.  In these cases, incidence or 
prevalence data estimated from 
sentinel populations would have to 
be compared with that estimated  
from cross-sectional population-based studies in order to assess which sentinel populations most 
closely represent the condition in the general population.  Additionally, sentinel surveillance may 
suffer from "participation" bias depending on the condition in question.  As is the case with 
service statistics, sentinel surveillance conducted at service-delivery points is representative only 
of the people who seek care at health-care centers.  With regard to HIV/AIDS, if testing is 
voluntary rather than unlinked and anonymous, results may not be valid nor representative 
because of the stigma attached to those infections.  Operationally, sentinel surveillance is 
impractical for dealing with the full panoply of reproductive health conditions.  A sentinel 
surveillance system can rarely be used to monitor trends of more than one unrelated condition at a 
time because each problem requires observation of a different sentinel population.  For instance, 
although a sentinel site established at an antenatal clinic may provide data on HIV/AIDS, as well 
as on several other STDs, such as syphilis, it would be a poor source of data for the prevalence of 
uterine prolapse in the community at large.  
 
Service-delivery-point-based Studies (SDP studies).  Typically, the information available to 
researchers concerning various aspects of reproductive health has been gathered from 
hospital- or clinic-based studies.  For the most part, information from clinics has been 
available on STDs, maternal mortality, and abortion whereas information on infertility and 
gynecological problems has been collected rarely.  Much of the current knowledge about the 
prevalence and distribution of STIs comes from studies of attendees of STD, antenatal or 
family planning clinics (Brunham and Embree 1992).  Similar situations exist for information 
about abortion and maternal mortality.  Clinic-based abortion research has provided 
information on the profile of abortion seekers (that is, about their age, parity, marital 
status, contraceptive use), on service-delivery issues such as complications observed and 
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Box 9:  Laboratory testing.  Laboratory 
results are meaningful only for conditions 
which are amenable for such testing, such as 
reproductive and urinary tract infections and 
anemia.  Laboratory tests, however, are often 
difficult to conduct under field conditions.  
Storage and transport of specimens to 
referral laboratories are problematic.  
Furthermore, some laboratory tests are 
expensive.  For many conditions, a variety of  
laboratory tests  some simple and some 
more complicated   can be used to detect a 
particular condition.  For example, testing 
for anemia can be performed by using 
simple procedures such as color coding of 
blood or by more detailed serological 
analysis.  Similarly, RTIs can be detected by 
a range of tests including simple microscopy 
of wet mounts to cultures.  Additionally, the 
prevalence of infections is an important 
predictor of detection.  In settings with low 
prevalence, it is easier to miss positive cases 
than in high prevalence settings.  Many 
gold standard tests are beyond field 
implementation and may not be suitable for 
community studies. 
types of procedures used, and on infection-prevention techniques employed, although these 
data may be thoroughly contaminated where abortion is illegal.  
 
SDP-based research is attractive for several reasons.  Foremost is the comparative ease of 
conducting clinical and laboratory investigations in settings where trained personnel and 
equipment are available.  This can result in substantial cost reductions for conducting 
research in medical settings.  Additionally, as noted above, clinic attendees, especially those 
showing no symptoms of the condition under study, form an important sentinel group for 
determining prevalence at the population level.  Finally, research focusing on service-delivery 
improvements is best conducted at SDPs.   
 
Although SDP-based studies can provide valuable information, as has been noted, they are 
not representative of the population at large because respondents are self-selected for the 
study.  As noted in our discussion of service statistics, for a variety of reasons, many women 
do not seek care at medical institutions.  Therefore, SDP-based studies do not provide insight 
into the prevalence of ailments and conditions in the general population. 
 
Community-based Studies.  Community-
based studies are an important innovative 
data-collection methodology that redress to 
some degree the inadequacies of SDP-
based and sample-survey data-collection 
methods.  Community-based studies have 
focused attention upon reproductive health 
issues.  For example, such studies 
conducted in Giza, Egypt (Zurayk et al. 
1995) and Gadchiroli, India (Bang et al. 
1989) provide information on the extent of 
gynecological symptoms and morbidity 
among women in the developing world.  
Increasing evidence that gynecological 
problems are not confined to clinic-based 
populations, but rather appear to be 
pervasive in the general population, has 
spurred innovative research in reproductive 
health.  These studies have provided a bank 
of substantive information, but have also 
raised a series of methodological issues. 
The term community-based study is used 
here to denote the in-depth study of 
particular villages or sites.  The sample in 
community-based studies may be smaller 
and less representative than are those found 
in sample surveys or population- 
based studies.  Typically, community-based 
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Box 10:  What are we talking about?  Disease, 
illness or sickness?  The use of several research 
methodologies simultaneously or sequentially 
ensures that community-based studies are more 
than a simple measurement of disease 
prevalence.  Indeed, by highlighting the social 
context in which reproductive morbidity is 
experienced such studies can provide a holistic 
view of reproductive health.  In this context, 
Zurayk and Kabakian (1996) stress the need to 
distinguish between disease, illness and sickness 
as the latter two provide a more complete 
description of an individuals experience of 
disease.  Indeed, the concepts of illness and 
sickness allow for an investigation of cultural 
explanations and perceptions of health and 
disease causation.  Furthermore, they provide a 
social meaning to health and ill health.  For 
example, it is frequently cited that often 
individuals do not recognize their ailment as a 
medical condition which requires attention or 
care.  An ethnomedical study in Rajasthan, India 
revealed that women suffering from a white 
vaginal discharge attributed it to physiological 
weakness resulting from poverty.  Thus, these 
women did not seek health care as they did not 
perceive the root cause of their discharge to be 
medical (Grant and Measham 1996). 
studies use a triangulation of measurement tools, collecting information from womens self-
reports of symptoms, from clinical examinations conducted by trained medical personnel, and 
from laboratory tests.  
 
Many community-based studies complement quantitative survey methods with qualitative 
methods in order to provide a rich tapestry of information about reproductive morbidity.  For 
instance, in Giza, Zurayk and her colleagues (1995) employed both a validation study and a  
series of auxiliary qualitative studies in an effort to better understand the context of womens 
reproductive health.  One such auxiliary study entailed case studies of women diagnosed as 
having gynecological problems in the initial study who were referred outside of the 
community for further medical care (Khattab 1992).  These case studies highlighted the role 
of the womans child-rearing responsibilities, the gender and generational hierarchies within 
households, and the culturally proscribed norms of tolerance and endurance in the womens 
recognition of illness and in their consequent patterns of health-seeking behavior.   
 
Community-based studies also 
highlight how women evaluate their 
symptoms in terms of the physical and 
social disturbance they cause and how 
this evaluation is translated into 
treatment-seeking behavior.  The Giza 
study showed that physical discomfort 
such as pain, itching, foul odor, or a 
feeling of wetness prompted women 
with a vaginal discharge to seek care.  
Results from that study also showed 
that the severity of the condition and 
the wider-ranging social and personal 
consequences of the ailment are 
significant factors in a womans 
decision to seek care.  Such findings 
have also been reported in community-
based studies conducted in India.  For 
example, one Indian study found that 
the severity of a discharge or menstrual 
problems prompted women to seek care 
(Kanani et al. 1994).  A second study 
conducted in India found that white 
discharge had implications for 
overall physical, mental, and sexual 
health.  In particular, white discharge 
was seen as causing a host of ailments 
including visual, gastric, and urinary 
problems, and general aches and pain 
(Bang and Bang 1994).  Moreover, this 
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Box 11:  How do you define the condition?  
Qualitative health research suggests that in many 
cultures and languages, a multitude of terms exists 
to denote the same reproductive health morbidity.  
Moreover, culture-specific constructs identify the 
term as either a positive or a negative manifestation.  
For example, Bang and Bang (1994) reported that in 
one Indian community, women used 12 different 
expressions and five major categories to describe 
white discharge.  Respondents may also use 
terminology that indicates conditions other than the 
literal meaning.  In India, weakness is often used 
to refer to a discharge (Koenig et al. 1996).  Clearly, 
if respondents are unable to understand the 
question, they will not be able to respond 
appropriately, and measurements will be affected.  
Investigators, too, need to understand the 
terminology and the meanings for the various 
conditions so that they can identify and classify 
them properly.  A fuller description of the condition 
usually facilitates a simpler and more accurate 
classification of the variable.  For example, a 
vaginal discharge can be described in terms of 
several characteristics such as volume, odor, 
consistency, and color.  Similarly, menstrual 
problems can be characterized by volume of 
bleeding, and by days of menstrual flow. 
same study highlighted the hierarchy of treatment in the informal health sector:  Women 
suffering from a white discharge initially treated themselves with home remedies provided by an 
elderly, experienced woman.  If no improvement followed this treatment, a traditional healer was 
consulted.  If the discharge was perceived to be the result of witchcraft, however, a witchcraft 
healer was sought.  Finally, an allopathic healer was visited only if all else failed and the 
resources to seek such care were available.   
 
Community-based studies, as conducted in recent years, however, have been shown to have several 
methodological flaws.  Studies aiming to measure levels of reproductive morbidity can be biased by 
the self-selection of respondents.  For instance, women who agree to participate in the study may do so 
in the hope of receiving advice or treatment for their ailments, whereas those who perceive themselves 
to be healthy may refuse to participate. The self-selection problem tends to be greater in studies that 
include a clinical examination than it is in those that use self-reported data on  
symptoms.  Such a situation inflates the variable under study by increasing the number of women 
whose positive responses are reflected in the numerator and by decreasing the number of women 
whose responses could potentially form part of the denominator. 
 
Several community-based studies have 
also reported substantial rates of sample 
loss for the clinical examination 
component of the study.  For example, 
seven community-based studies 
conducted in India (Koenig et al. 1996) 
all noted significant sample loss as 
great as 80 percent.  Similar results are 
reported for neighboring Bangladesh 
where 24 percent of symptomatic 
women refused clinical examination 
after being interviewed (Wasserheit et 
al. 1989).  By ways of contrast, a 
community-based study in Turkey was 
successful in examining 80 percent of 
the respondents who had participated in 
the home interviews and, similarly, in 
the Giza study, 91 percent of the 
women interviewed were later 
examined (Bulut et al. 1995; Zurayk et 
al. 1995).  Although culture-specific 
reasons may explain the varying levels 
of participation in the different phases 
of the studies, differential efforts of 
health-care providers to build rapport 
with the community may also account 
for these differences.  These results 
highlight the need to establish rapport 
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with the community and with key household decisionmakers, including husbands and 
mothers-in-law, before beginning study-sample recruitment. 
 
Underreporting of morbidities is another important methodological problem with studies that 
rely on self-reports of symptoms, such as those that are community-based.  Two longitudinal 
studies conducted in India found that more women reported a gynecological morbidity in the 
latter rounds of a survey than in the initial ones (Koenig et al. 1996).  Another study of more 
than 270 women conducted in northern India reported a greater than seven-fold increase 
(from 5 percent to 38 percent) in the number of respondents reporting a gynecological 
problem over the course of a year (Koenig et al. 1996).  A study of postpartum women in 
Bangladesh (Goodburn and Graham 1996) showed that reports of reproductive morbidity 
increased during the four-week study period.  Indeed, validation by physical examination
for those conditions that could be confirmed by a physical examination, such as lower 
abdominal painshowed that although an increase occurred in the reporting of the symptom, 
no corresponding increase was evident from clinical diagnosis. 
 
To date, comparing results from community-based studies has been difficult because standard 
definitions for many common reproductive health problems have not been established.  
Definitions of STIs, for instance, have varied widely, leading to confusion and to questions 
about the interpretations of available data.  Indeed, variations in definitions have led to 
differing estimates of the prevalence of the same STIs in one community (see Box 1).  
Therefore, although several studies suggest that STIs and RTIs are major causes of morbidity, 
the scope of this problem remains uncertain. 
 
Although community-based studies have dealt effectively with several shortcomings of 
traditional data sources, several important measurement issues remain unresolved.  Further 
work is required to develop and validate standards for measuring the reproductive health of 
women on a community level.    
 
Section 6.  Examples of Indicators 
 
In the previous sections, we reviewed the purposes for which indicators may be used, criteria 
for assessing their usefulness, and possible data sources.  In this section, we draw on the 
concepts summarized earlier and discuss the effectiveness and limitations of a few sample 
indicators. 
 
The maternal mortality ratio measures the annual number of maternal deaths per 100,000 
live births. Maternal deaths are rare events even in settings with high maternal mortality, and 
they require large sample sizes from which to derive reliable estimates.  Field-workers for the 
Indian DHS, for example, interviewed nearly 90,000 women (the largest DHS conducted to 
date) to derive a maternal mortality ratio of 437 deaths per 100,000 live births for the two-
year period preceding the survey (IIPS, 1995).  Despite the large sample size, the sampling 
errors for the maternal mortality estimates are large.  In many settings, classification of the 
cause of the death is extremely difficult, especially where a large proportion of deaths occur 
outside of institutional settings.  Deaths from complications of abortion may be misreported 
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or underreported where such procedures are illegal.  Similarly, many deaths of pregnant 
women resulting from domestic violence are not reported as maternal deaths.  For these 
reasons, the maternal mortality ratio is not an appropriate indicator for assessing effectiveness 
of safe motherhood programs at the district level.  It can be used, however, as an indicator to 
measure progress at the national level.   
 
The percentage of deliveries attended by trained personnel and the percentage of 
institutional deliveries are indicators of the coverage of delivery services.  These percentages 
can also be used to measure access to and use of delivery services and are often used to 
monitor program performance at both national and subnational levels.  The numerators of 
these indicators are the numbers of deliveries attended by trained personnel and the numbers 
of deliveries occurring in institutions, respectively.  In both instances, the denominator is the 
total number of deliveries occurring in the reference period.  Robust indicators of the use of 
delivery services can be derived from sample surveys, because these can provide information 
for both the numerator and the denominator.  However, if service-delivery statistics or other 
institutional records are used to generate data, detailed information on the numerator may be 
available, but the denominator is usually based on estimates of the projected number of 
deliveries occurring in the area in the reference period.  The representativeness of this 
indicator depends on the proportion of births that occur at health-care facilities, and the 
accuracy of the reports of the total number of births in the reference period. 
 
The indicator reported rate of non-accidental injury to women aged 15-44 has been 
developed to assess the level of violence against women in an effort to inform policy and  to 
plan effective programs.  The data requirements for this indicator are complex.  In order to 
obtain an accurate picture of the level of violence, data are required on all reported cases of 
violence from several sources, including police stations, health institutions, crisis centers, and 
womens shelters.  Because a considerable proportion of violent episodes are never reported 
to any institution, the indicator is likely to underestimate the true incidence of violence 
against women, even if data are collected from a number of sources.   Although sample 
surveys may include questions on violence, levels of non-response or misreporting tend to be 
high.  Similarly, although health-care institutions may offer an estimate of the proportion of 
clients who are victims of violence, women seeking care at those institutions may over-
represent those who are severely injured because those not seeking care or seeking care 
outside the formal sector will be ignored. 
 
The indicator percentage of men with urethritis attempts to assess the extent of potential STIs 
among men in the general population.  Data for this indicator traditionally come from sample 
surveys: men are either asked about symptoms or provide a semen sample.  Self-reporting of 
symptoms suffers, however, from the problems discussed earlier, and the collection of 
specimens is time consuming, expensive, and often infeasible.  For these reasons, collection 
of accurate data for the numerator is difficult, resulting in a poor indicator and potentially 
erroneous conclusions about STI prevalence in the general population.  If the purpose of the 
indicator is not to assess the true prevalence of urethritis, however, but rather to indicate 
minimum levels of infection for advocacy and planning purposes, the indicator may be 
sufficient.   
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Section 7. Other Work in the Field of Reproductive Health Indicators 
 
General activities in the field of reproductive health indicators over the past few years are 
reviewed below.  Most efforts have been aimed at developing national-level, aggregate 
indicators and little, if any, attention has been allotted to community-level indicators. 
 
WHO   WHO has been one of the forerunners in the development of reproductive health 
indicators.  Following the World Summit for Children in 1990, the organization has 
collaborated with UNICEF (see below) to generate a list of indicators for assessing progress 
toward the summit's goals.  In recent years, the family and reproductive health unit has also 
worked specifically to develop reproductive health indicators and has delineated selection 
criteria for these indicators, as described in section 3. After hosting the Interagency Technical 
Meeting on reproductive health indicators in early 1997, WHO proposed a list of 13 
reproductive health indicators to serve as a useful minimum. 
 
UNICEF   UNICEF has been working for several years to develop indicators to monitor 
progress toward the specific targets set at the 1990 World Summit for Children.  The agency 
initially produced a list of impact and process indicators for assessing progress toward the 
Mid-decade Goals and have worked since with WHO to expand the earlier list to evaluate 
global goals for the year 2000.  Only a few of these indicators are related to reproductive 
health.  In 1995, UNICEF also issued the second edition of "Maternal Mortality: Guidelines 
for Monitoring Progress" (Maine et al. 1995).  In this publication, the authors review ten 
indicators related to safe pregnancy. 
 
UNFPA   At the initiation of advisors from the Country Support Teams, the Technical and 
Evaluation Division of the United Nations Population Fund (UNFPA) has been working 
since 1994 to develop a list of indicators for assessing the components of reproductive health 
identified at the ICPD.  They have created a list of 70 indicators, which include both 
quantitative and qualitative types. 
 
USAID   USAID has funded the EVALUATION Project to coordinate multi-disciplinary 
subcommittees of the Reproductive Health Indicators Working Group, to review existing 
indicators and to develop new indicators of reproductive health. The project has focused 
almost exclusively on indicators for evaluating the output or outcome of programs rather than 
on assessing needs or evaluating health status.  Subcommittees were convened on safe 
pregnancy, breastfeeding, sexually transmitted diseases and AIDS, adolescence, and maternal 
nutrition.  Each subcommittee was asked to provide a short list of 59 indicators.  
Interestingly, the subcommittee on family planning did not produce a short list, but rather 
offered 95 indicators, stating that the choice of key indicators for evaluating family planning 
programs worldwide depends entirely on the purpose of the evaluation.  
 
Section 8.  Conclusion 
 
In this paper, the importance of using appropriate indicators for the purpose required is 
emphasized.  Indicators required for program monitoring and evaluation are necessarily 
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different from those required for outcome or impact measurement.  A similar distinction is 
necessary for indicators used at different levelsnational, subnational, or those used for a 
specific program.   
 
Although a considerable bank of knowledge concerning reproductive health issues exists that 
is based on service-delivery-point data, the recent advances in community-based research 
have added significantly to the measurement of reproductive health status.  Community-based 
studies have highlighted new problems and important areas for workboth in terms of 
necessary interventions and improved services and in light of the need to develop and 
validate good reproductive health indicators.  This method of measurement should be 
expanded in order to gather information about different populations of women in a variety of 
regions and cultures.  For this endeavor to be successful, however, a standard protocol for 
conducting studies must be developed.  Second, the indicators employed must be validated 
for technical soundness to ensure that they will provide comparable data.  Once the results of 
these studies are applied more broadly, and appropriate interventions are identified and 
implemented, the routine suffering of women resulting from unmeasured reproductive 
morbidity can be addressed and perhaps alleviated. 
 
The knowledge derived from community studies can form the basis for the design of larger-
scale studies that are replicable and sustainable.  The possibility of including questions on 
reproductive health in large-scale surveys has to be explored more rigorously.  Questions on 
reproductive behavior and attitudes toward family planning were once considered to be too 
personal or sensitive, and thus were likely to elicit responses that were invalid or unreliable.  
Determining more effective ways of asking questions and identifying which questions to ask 
has led to the development of better questions that yield both valid and reliable answers that  
can be included routinely in large-scale surveys.  The limitations of such surveys cannot be 
ignored, however.  Only when a variety of data-collection methods are developed, all of 
which provide valid and reliable information, will the true picture emerge showing the 
reproductive health status of the worlds women that is necessary for program design, 
evaluation, and monitoring.   
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Appendix I:  How Indicators are Derived 
 
With the present focus in the reproductive health community on health status, the presence or 
absence of a specific illness or condition among a population is a matter of general interest.  
In many instances, we rely upon epidemiological measures of disease frequency to 
summarize the distribution of disease among different groups.  
 
The most basic measure of disease frequency is a simple count of cases of the illness or 
condition of interest.  Such figures are important for strategic planning in the health system, 
and for allocating scarce health-care resources.  Counts of cases provide an idea of the 
number of people who will require a specific health service or treatment.  Counts of cases, 
however, reflect the size and composition of the population from which those cases arose.  In 
order to compare the disease burden of different populations, or of subgroups in a single 
population, the base population from which cases arise and the time period of data collection 
must be considered as well. 
 
The most commonly used and simplest type of indicator that includes a measurement of the 
base population is a proportion.  A proportion is a ratio in which the numerator is a part of 
the denominator, and it is usually expressed as a percent.  Some examples include the fetal 
death rate (that is, the number of fetal deaths/the number of births where the number of 
births is defined as live births plus fetal deaths); the percent of women giving birth in a 
health-care facility (that is, the number of women giving birth in a health-care facility/the 
number of women giving birth); and the case fatality "rate" (that is, the number of deaths due 
to a condition/the total number of cases with that condition).  
 
A ratio involves a comparison of a numerator and a denominator in which the numerator is 
not a part of the denominator.  For example, in the maternal mortality ratio (that is, the 
number of maternal deaths/the number of live births), the numerator does not figure in the 
denominator. 
 
The word rate must be used and interpreted with caution.  In the public health literature, the 
term refers loosely to measures that are actually ratios or proportions, rather than true rates.  
A true rate includes a measure of time in the denominator.  The denominators of true rates 
are measures of person-time, for example, person-years or person-months.  Denominators of 
true rates are population measures rather than events, such as births or deaths. 
 
Prevalence is a measure of the number of persons having a specific condition or illness at a 
designated time.  It is defined as the number of existing cases/total population from which 
those cases arose.  All prevalence measures are also proportions, and can be interpreted as the 
risk of any individual in the population of having the condition of interest at one particular 
time.  In terms of reproductive health indicators, the prevalence of a variety of STIs or 
conditions such as uterine prolapse might be of interest.  Prevalence incorporates a measure of 
the size of the population from which the cases arose.  When comparing the prevalence (or in 
fact any measure of disease frequency) of certain conditions between groups, however, the 
definition of a case must be consistent for all groups, and the populations must be 
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Box 12:  Incidence vs. Prevalence.  
Incidence is inherently difficult to measure 
for illnesses because such a measure 
requires that a cohort of individuals from 
the population of interest be followed over a 
period of time.  This procedure is both 
costly and time consuming.  Consequently, 
prevalence measures are often used instead 
because they can be determined from the 
data  gathered in cross-sectional surveys.  
Caution must be used when prevalence 
measures are interpreted, however, because 
prevalence is a reflection both of the 
incidence of disease in the population and 
of the average duration of the disease or 
condition.  The duration of disease is  
influenced in turn by other factors such as 
the availability and effectiveness of 
treatment and the screening measures 
employed. 
comparable.  Differences in the age structure or other characteristics between populations may 
lead to incorrect conclusions about the relative importance of a condition in each population. 
 
Incidence is a measurement of the 
frequency at which new cases of a 
specific condition or illness arise in a 
given population over a specified period 
of time.  Cumulative incidence (that is, 
the number of new cases of disease 
arising during a given period of time/total 
population at risk) can be interpreted as 
an estimate of the probability or risk that 
an individual will develop the condition 
of interest during a particular period.  The 
period involved can be a number of years 
or can refer to periods in an individuals 
life (for example, before age ten).  This 
measure implies that all of the individuals 
under study were followed for the entire 
time period delineated; in other words, 
the cohort from which the information is 
derived cannot experience any loss to 
follow-up.  In terms of reproductive  
health indicators, a womans lifetime risk 
of developing cervical cancer, or the number of women who present with RTI symptoms over 
a certain period of time might be of interest.  
 
The incidence rate is defined as the number of new cases in a period of time/ total person-
time of observation. When calculating incidence rates, individuals can be followed for 
various lengths of time and can contribute differing amounts of time to the denominator.  
Such calculations assume that all the individuals all have equivalent susceptibility and, 
consequently, that time contributed from different individuals is interchangeable (for 
example, following eight individuals for two years would yield the same data as would 
following 16 individuals for one year).  Looking at the incidence rate of a particular 
condition provides an idea of the frequency with which individuals experience that 
condition.  For example, the incidence of HIV seropositivity indicates the rapidity of the 
spread of infection in a particular population.  Comparing the incidence between different 
populations may help make clear which factors affect the spread of infection. 
 
In addition to the measures mentioned above, other indicators are derived using demographic 
methods and, essentially, are averages of a specific condition of interest.  Examples include 
life expectancy at birth, at other ages, or at a certain time (these data can be disaggregated by 
sex), and the total fertility rate, which is an estimate of the average number of children a 
woman would have should she experience over her lifetime the fertility rates that exist 
currently for women in every age group. 
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